Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
-4.24x1.58x0.33x4.27x-2.53x-2.4x-.--% 13.4B
19.53x2.56x3.05x5.29x13.42x16.08x0.46% 81.73B
56.58x7.61x1.35x14.96x32.09x40.18x-.--% 59.54B
42.74x4.44x6.82x6.63x21.32x29.35x0.55% 56.31B
22.2x2.78x-1.48x4.06x11.8x13.62x2.65% 56.11B
18.08x1.49x-2.52x2.97x9.38x10.37x-.--% 27.52B
17.25x3.64x0x3.41x10.25x10.4x-.--% 20.98B
81.91x7.95x-0.05x9.72x87.64x100.57x-.--% 19.71B
376.68x68.1x22.63x114.3x185.72x190.17x - 18.72B
-22.56x-7.29x-1.19x32.45x-33.11x-32.11x-.--% 14.89B
-623.6x2.92x5.94x4.54x11.82x25.56x-.--% 13.01B
20.99x1.84x0.78x3.16x14.65x15.39x-.--% 11.33B
-16.16x - -0.29x581.54x-15.93x-16.09x-.--% 10.9B
6.35x2.64x0.02x2.89x4.35x4.4x2.87% 8.86B
-44.49x192.67x1.22x13.34x-55.81x-49.25x-.--% 8.54B
-258.74x - 0.79x - - - -.--% 8.48B
18.11x1.22x0.1x2.12x8.8x11.72x1.43% 8.05B
38.95x - 0.31x18.2x42.6x43.48x-.--% 7.58B
Average -13.91x 19.61x 2.10x 48.46x 20.38x 24.20x 0.47% 24.76B
Weighted average by Cap. 17.10x 10.19x 2.41x 26.72x 23.15x 27.52x 0.6%
Biopharmaceuticals